Nalaganje...

Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia

This study was conducted to investigate the outcomes of patients with chronic myeloid leukemia (CML) who discontinued tyrosine kinase inhibitor (TKI) treatment. A single-center retrospective analysis was performed, including 46 chronic-phase (CP) CML patients who achieved complete molecular response...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Clin Oncol
Main Authors: TSUTSUMI, YUTAKA, ITO, SHINICHI, OHIGASHI, HIROYUKI, SHIRATORI, SOUICHI, TESHIMA, TAKANORI
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727029/
https://ncbi.nlm.nih.gov/pubmed/26870364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.653
Oznake: Označite
Brez oznak, prvi označite!